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Abstract Phosducin and related proteins have been identified as
ubiquitous regulators of signalling mediated by LQ subunits of
trimeric G proteins. To explore a role for phosducin in regulated
exocytosis, we have examined the distribution and putative
function of phosducin-like protein (PhLP) in adrenal medullary
chromaffin cells. The full-length cDNA encoding the short splice
variant of PhLP (PhLPs) was cloned from cultured chromaffin
cells. Native PhLPs was found associated with plasma mem-
branes and detected in the subplasmalemmal area of resting
chromaffin cells by confocal immunofluorescence analysis.
Stimulation with secretagogues triggered a massive redistribu-
tion of PhLPs into the cytoplasm. When microinjected into
individual chromaffin cells, recombinant PhLPs inhibited cate-
cholamine secretion evoked by a depolarizing concentration of
K+ without affecting calcium mobilization. Thus, PhLPs may
participate directly in the regulation of calcium-evoked
exocytosis. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
In addition to their well known role in signal transduction,
heterotrimeric G proteins participate in the regulation of in-
tracellular membrane tra⁄cking events (reviewed in [1,2]), in-
cluding direct control of calcium-evoked exocytosis [3^6].
Although GK subunits clearly regulate certain aspects of exo-
cytosis [5^8], the GLQ complex has also been implicated [9^11].
Indeed, GLQ can interact directly with a variety of e¡ectors
displaying a pleckstrin homology (PH) domain [12^15], in-
cluding phosphatidylinositol 3-kinase [16] involved in the exo-
cytotic process in chroma⁄n cells [17]. In addition, we re-
cently described that GLQ complexes mediate the binding of
the ADP-ribosylation factor 6 to secretory granule mem-
branes [18], and this may be crucial to the late stages of
exocytosis [19,20].
The responsiveness of G protein-regulated pathways may
be directly modulated through interactions of GLQ subunits
with intracellular regulatory proteins. Phosducin and related
proteins constitute a family of ubiquitous GLQ regulators.
Phosducin (Phd) and a long splice variant of Phd named
phosducin-like protein 1, as well as two splice variants from
a second gene, PhLPs (short variant) and PhLPl (long var-
iant), directly interact with GLQ [21] and thereby inhibit the
GTPase activity and signaling function of various trimeric G
proteins [22,23]. Phosducin-like proteins also impair GLQ-
mediated functions by competing with several GLQ e¡ectors
[24,25]. Phosphorylation of Phd dissociates it from GLQ, al-
lowing GK to rapidly reassociate with GLQ [22,26,27]. Thus,
Phd modulation of GLQ signaling itself may be regulated by a
feedback loop involving phosphorylation. The mechanism of
interaction of Phd and GLQ has been clari¢ed by the recent
crystal structure of the Phd^GLQ complex [26,28], in combi-
nation with mutational and biophysical analysis [29,30]. The
N- and C-terminal ends of Phd appear to envelop two faces of
the LQ propeller to form an extensive interaction surface.
Although they have not been crystallized yet, PhLP proteins
which present 65% amino acid homology with Phd are pre-
sumed to have a similar three-dimensional structure [31].
Phd is expressed at high levels in retinal rod cells [32] where
it plays an important role in light adaptation [33]. The precise
cellular functions of PhLPs and PhLPl remain unknown.
Their di¡erent tissue distribution suggests that PhLP proteins
represent functional counterparts of Phd in the regulation of
trimeric G proteins [21,32,34]. Here, we report cloning of
PhLPs from cultured bovine chroma⁄n cells. Microinjection
of recombinant PhLPs inhibited secretion from single chro-
ma⁄n cells at a stage distal from calcium entry. Our ¢ndings
support the hypothesis that PhLPs may participate in the
regulation of calcium-dependent exocytosis from neuroendo-
crine cells.
2. Materials and methods
2.1. RNA isolation, cDNA ampli¢cation and sequencing
Total RNA was isolated from cultured chroma⁄n cells (1.3U106
cells/assay). 1 Wg of total RNA was transcribed into cDNA with
Superscript RNase H3 reverse transcriptase (Gibco-BRL, France)
and an oligo(dT) primer. 2-Wl aliquots of the cDNA were used as
template for PCR (total volume of 50 Wl) using Taq polymerase
(MBI Fermentas) and speci¢c primers. Expression of bovine PhLP
cDNA was tested with primers 5P-CATATGACAAGTTGCTGGGG-
GAGAAATTG-3P and 5P-GGATCCTCAATCTATTTCTAGATC-
GCTGTCTT-3P for the long variant of PhLP and with primers 5P-
CATATGGAGCGGCTGATCAAAAAGCTGTC-3P and 5P-GGAT-
CCTCAATCTATTTCTAGATCGCTGTCTT-3P for the short var-
iant of PhLP [35]. The PCR products were puri¢ed and directly li-
gated into the TA cloning vector (pMOSBlue T-vector Kit, Amer-
sham). DNA sequence analysis was done on both strands. The bovine
PhLPs sequence reported in this paper has been deposited in the
EMBL database (accession number AJ277994) and GenBank data-
base (accession number AF242854).
2.2. Expression and puri¢cation of recombinant 6His-PhLPs
PhLPs cDNA was inserted into the pET14b vector (Novagen) using
the NdeI and BamHI sites. Large-scale production of 6His-PhLPs was
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performed as described previously [36]. Fusion proteins, puri¢ed on a
nickel a⁄nity column (Novagen), were V90% pure as estimated by
Coomassie staining after SDS^PAGE. Recombinant 6His-PhLPs was
dialyzed against 10 mM PIPES, 50 mM K-glutamate.
2.3. Culture of chroma⁄n cells and subcellular fractionation
Chroma⁄n cells were isolated from fresh bovine adrenal glands and
maintained in primary culture as described previously [6]. Experi-
ments were carried out on 3^7-day-old cultures. Cultured chroma⁄n
cells were collected in bu¡er A (0.32 M sucrose, 10 mM Tris, pH 7.4),
homogenized and then centrifuged at 800Ug for 15 min. The post-
nuclear supernatant (H1) was subsequently centrifuged at 20 000Ug
for 20 min. The supernatant (S1) was used to purify microsomes (P2)
from cytosol (S2) after 45 min centrifugation at 100 000Ug. The pellet
(P1) containing crude membranes was resuspended in bu¡er A, lay-
ered on a continuous sucrose density gradient (sucrose 1^2.2 M), and
centrifuged for 90 min at 100 000Ug. Twelve 1-ml fractions were
collected from top to bottom. The distribution of dopamine-L-hydrox-
ylase (DLH, chroma⁄n granule marker) and Na/K ATPase (plas-
ma membrane marker) in the fractions of the gradient was estimated
as described previously [8].
2.4. Microinjection, [Ca2+]i measurement and electrochemical
detection of catecholamine secreted from single cells
Microinjection of PhLPs in 10 mM PIPES, 50 mM K-glutamate,
pH 7.4 or bu¡er alone was performed as described earlier [37]. The
calculated injected volume represented 50^100 £. Single cell [Ca2]i
assay was performed using the £uorescent Ca2 indicator Indo 1-AM
(Molecular Probes) [38]. Electrochemical measurements of catechol-
amine secretion were performed 30 min after microinjection [37]. Cat-
echolamine secretion was evoked by applying K (100 mM) in
Locke’s solution without ascorbic acid for 5 s to single cells by means
of a glass micropipette positioned at a distance of 100 Wm from the
cell. The amplitude of secretion was quanti¢ed by measuring the area
below the current curve using the MacLab system.
2.5. Antibodies and immunocytochemistry
Polyclonal anti-PhLPs antibodies were raised in rabbits against re-
combinant 6His-PhLPs and a⁄nity-puri¢ed as described [39]. Rat
polyclonal antibodies against DLH were prepared in our laboratory;
their speci¢city has been previously demonstrated [37]. Secondary
antibodies (goat anti-rat conjugated to Cy2 and goat anti-rabbit con-
jugated to Cy3) were purchased from Amersham (Les Ulis, France).
Immunocytochemistry was performed as described previously [37].
Stained cells were monitored using the Zeiss laser scanning micro-
scope (LSM 410 invert) with an oil immersion lens (63U).
2.6. GTPase activity of puri¢ed granule membranes
The GTPase activity was assayed by incubating plasma (0.5 Wg) or
secretory granule (1 Wg) membranes for 10 min at 30‡C with the
indicated concentrations of PhLPs as described earlier [8]. Non-enzy-
matic hydrolysis of [Q-32P]GTP during the assay was subtracted from
all data.
3. Results and discussion
3.1. Presence of PhLPs in the chroma⁄n cell plasma
membrane
We ¢rst examined the expression of PhLP in chroma⁄n
cells by RT-PCR using speci¢c primers for PhLPs and PhLPl.
A single band of 660 bp was detected with the primers for
PhLPs. No band for PhLPl was found in three separate ex-
periments performed with two distinct cDNA preparations.
The 660-bp PCR product obtained from chroma⁄n cells
was cloned and sequenced; it presented 86% analogy at the
nucleotide level to the rat PhLPs sequence [35]. These results
suggest that only the PhLPs mRNA (and not PhLPl) is ex-
pressed in chroma⁄n cells. The putative open reading frame
Fig. 1. Comparison of amino acid sequences of PhLPs from bovine,
human and rat. The deduced amino acid sequences from human
[45] and rat [35] PhLPs were aligned with bovine PhLPs using
SeqApp. Identical amino acids are highlighted.
Fig. 2. Immunochemical detection of PhLPs in subcellular fractions
from chroma⁄n cells. A: Cultured chroma⁄n cells were collected,
homogenized and processed for subcellular fractionation. Protein
(100 Wg) from the total homogenate (H1), the crude membrane pel-
let (P1), cytosol (S2) and microsomes (P2) was subjected to SDS gel
electrophoresis and immunodetection on nitrocellulose using anti-
PhLPs antibodies (diluted 1:100). Note the absence of a 45-kDa
band corresponding to PhLPl. Position of protein standards (kDa)
is on the right. B: Twelve fractions collected from a continuous su-
crose density gradient layered with the crude membrane pellet (P1)
were assayed for Na/K-ATPase activity (expressed as arbitrary
units). C: Proteins (50 Wg) from each fraction were separated by
SDS gel electrophoresis, transferred and analyzed with anti-PhLPs
antibodies (diluted 1:100). Recombinant PhLPs (250 ng) was used
as positive control (R). Position of protein standard (kDa) is on the
left. Similar results were obtained in two independent experiments.
FEBS 24041 28-8-00
M. Gensse et al./FEBS Letters 480 (2000) 184^188 185
of the bovine PhLPs consists of 654 nucleotides encoding a
protein of 218 amino acids. The deduced amino sequence of
the bovine PhLPs is strikingly similar to human and rat se-
quences with 91% and 90% identity and with 96% and 95%
homology, respectively (Fig. 1). Bovine PhLPs contains po-
tential phosphorylation sites for protein kinase A at Ser9 and
for protein kinase C at Thr37 ; the latter is equivalent to Ser73
in Phd. The major di¡erence between bovine and rat PhLPs is
localized between amino acids 40 and 48 (Fig. 1). Although
this region is unlikely to a¡ect the overall structure of bovine
PhLPs because it makes a loop between the GL-interacting H2
and H3 helices, it could be important for interaction with
e¡ectors. Interestingly, the carboxy-terminal region, which is
known to contain contact sites between PhLP and GL, is
highly conserved.
Expression of PhLP in chroma⁄n cells was assessed by
Western blotting using a polyclonal antibody raised against
the recombinant bovine PhLPs. A single immunoreactive
band of 29 kDa was detected in homogenates prepared
from cultured chroma⁄n cells (Fig. 2A), con¢rming that
PhLPs was indeed expressed, but not PhLPl. To evaluate
the portion of cytosolic and membrane-bound PhLPs, the
homogenate was separated into a crude membrane fraction
(P1), the cytosol (S2), and microsomes (P2). PhLPs was de-
tected only in the crude membrane fraction (Fig. 2A). This
observation is in marked contrast with the reported cytosolic
localization of Phd in retinal rod cells [32].
The association of PhLPs with a distinct membrane com-
partment was further probed by separating the crude mem-
brane preparation on a sucrose density gradient. We found
that PhLPs was predominantly localized in fractions 2^4 cor-
responding to the plasma membranes as indicated by the
ATPase Na/K activity (Fig. 2B,C), and absent in chromaf-
¢n granule-enriched fractions 10^12 [8].
3.2. PhLPs translocates from plasma membrane to the cytosol
upon cell stimulation
The intracellular distribution of PhLPs was next character-
ized by immuno£uorescence and confocal microscopy in rest-
ing and stimulated chroma⁄n cells. Exocytosis was visualized
by stimulating cells in the presence of anti-DLH antibodies
[37]. DLH is localized on the inner surface of secretory gran-
ules and becomes exposed on the external surface of the plas-
ma membrane during secretion, thereby revealing exocytotic
sites by the appearance of £uorescent patches at the cell sur-
face. Cytosolic PhLPs was virtually undetectable in resting
chroma⁄n cells (Fig. 3A), con¢rming the results obtained
by subcellular fractionation and immunoreplica analysis.
PhLPs immunoreactivity was almost exclusively detected in
the subplasmalemmal region. In marked contrast, stimulation
with 10 WM nicotine triggered both the formation of DLH
£uorescent patches at the cell surface, and signi¢cant immu-
nostaining for PhLPs within the cytosol (Fig. 3A). To quan-
tify this apparent translocation of PhLPs, we compared the
amount of PhLPs in membrane and cytosolic fractions pre-
pared from resting and nicotine-stimulated chroma⁄n cells.
As illustrated in Fig. 3B, immunoreplica analysis revealed a
signi¢cant reduction in the level of membrane-bound PhLPs
Fig. 3. PhLPs translocates from the cell periphery to the cytosol upon cell stimulation. A: Chroma⁄n cells were incubated for 10 min in
Locke’s solution (Resting) or in Locke’s solution containing 10 WM nicotine (Stimulated) in the presence of anti-DLH antibodies (diluted 1:50)
to visualize exocytotic activity (DLH). Cells were then ¢xed, washed and stained with a⁄nity-puri¢ed anti-PhLPs antibodies diluted 1:5
(PhLPs). DLH immunoreactivity was visualized with anti-rat antibodies conjugated to Cy2 (diluted 1:2000) and PhLPs was revealed with anti-
rabbit antibodies conjugated to Cy3 (diluted 1:2000). Note that DLH exocytotic patches were only observed in stimulated cells, which also dis-
play a marked increase of cytosolic PhLPs immunoreactivity. Similar observations were made with three di¡erent cell preparations. Bar = 5 Wm.
B: Cultured chroma⁄n cells (106 cells) were incubated for 10 min in Locke’s solution (R) or stimulated with 10 WM nicotine (S). The incuba-
tion media were collected and secretion of endogenous catecholamine was veri¢ed by reverse phase high performance liquid chromatography.
Cells were then scraped in 800 Wl phosphate bu¡er, broken by three freeze and thaw cycles, and centrifuged at 100 000Ug for 60 min. Mem-
brane-bound (pellet) and cytosolic (supernatant) proteins were separated by gel electrophoresis and analyzed for the content of PhLPs by im-
munodetection on nitrocellulose. The density of the immunoreactive PhLPs band was quanti¢ed using the Fuji L phosphorimager and expressed
as arbitrary unit (A.U.). Similar results were obtained with two distinct cell preparations.
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and a 12-fold increase of soluble cytosolic PhLPs in stimu-
lated cells. Overall, these results indicate that a portion of the
plasma membrane-associated PhLPs translocates to the cyto-
sol during the exocytotic reaction, thus suggesting that PhLPs
may be involved in the molecular machinery underlying secre-
tion in chroma⁄n cells.
3.3. Recombinant PhLPs inhibits exocytosis in single
chroma⁄n cells
To study the potential role of PhLPs in the exocytotic pro-
cess, we expressed and puri¢ed recombinant 6His-PhLPs. Phd
and related proteins are known to inhibit intrinsic GTPase
activity of several trimeric G proteins. Phd is not a direct
inhibitor of the G protein GTPase but, via its interaction
with GLQ, it slows the release of GDP from GK. This results
in an increase of the fraction of GDP bound and ultimately
leads to an inhibition of steady-state GTPase activity [40]. We
used this assay to determine the activity of recombinant
PhLPs. In chroma⁄n cells, Go is preferentially associated
with the membrane of secretory granules, whereas Gi3 is es-
sentially concentrated at the plasma membrane [6,8]. In puri-
¢ed chroma⁄n granule and plasma membrane preparations,
PhLPs inhibited GTPase activity in a similar dose-dependent
manner (Fig. 4), suggesting that recombinant PhLPs was in-
deed able to modulate both the granule-bound Go and the
plasma membrane-associated Gi3. These results are in agree-
ment with PhLP and LQ subunits being in competition for
GKo and GKi3 [41].
The secretory granule-associated Go protein has been pro-
posed to control the priming of exocytosis [6], whereas the
plasma membrane-bound Gi3 protein is probably involved
in the late calcium-dependent fusion step [8]. Because re-
combinant PhLPs was apparently active on both GTPases
in vitro (Fig. 4), we investigated whether PhLPs might partic-
ipate in the regulation of the exocytotic machinery in chro-
ma⁄n cells. A robust rise in the cytosolic calcium concentra-
tion [Ca2]i is a prerequisite for exocytosis. To measure the
transient increase of [Ca2]i in response to a depolarizing
concentration of K, individual chroma⁄n cells were micro-
injected with bu¡er, then stimulated 10^15 min later by a local
application of 59 mM K, and [Ca2]i was recorded. As
shown in Fig. 5A, K-evoked stimulation induced a rapid
rise of [Ca2]i that lasted for about 60 s. When the same
cell was allowed to recover for 30 min and microinjected
with 10 WM PhLPs, the [Ca2]i signal in response to a second
K stimulation was identical (Fig. 5A). Thus, PhLPs did not
a¡ect the rise of cytosolic calcium triggered by cell depolari-
zation. In parallel, we estimated the secretory response to K
by electrochemically recording catecholamine release. As illus-
trated in Fig. 5B, microinjection of 10 WM PhLPs inhibited by
approximately 75% the release of catecholamines compared to
the ¢rst secretory response obtained after bu¡er injection (Fig.
5B), and this inhibitory e¡ect was dose-dependent (Fig. 5C).
Thus PhLPs blocked exocytosis without interfering with the
mobilization of calcium, suggesting that PhLPs might directly
play a function in the exocytotic machinery in chroma⁄n
cells.
Fig. 5. E¡ect of PhLPs on high K-evoked catecholamine secretion
from single chroma⁄n cells. Indo-1-loaded chroma⁄n cells were mi-
croinjected with bu¡er, incubated for 10 min in Locke’s solution
and then stimulated by a local application of 59 mM K (Control).
The same cell was then allowed to recover for 30 min in Locke’s so-
lution, microinjected with PhLPs (PhLP 10 WM), incubated for
10 min and stimulated for a second time with 59 mM K. A: Var-
iations in cytosolic [Ca2]i after the ¢rst and the second stimuli
were recorded on-line as a voltage signal (F405/F480 ratio). Represen-
tative traces of [Ca2]i transients in response to a 5-s 59 mM K
pulse (arrowhead) are shown. B: Catecholamine secretion was re-
corded in parallel by amperometry using a carbon ¢ber electrode.
Microinjection of 10 WM PhLPs did not signi¢cantly modify the
[Ca2]i transient but strongly inhibited the exocytotic release of
catecholamines as revealed by the reduced amperometric response.
C: Cells were microinjected with bu¡er (n = 33), 2.5 WM (n = 25),
5 WM (n = 20) or 10 WM (n = 10) recombinant PhLPs and after
20 min stimulated with high K. The amperometric response was
integrated to obtain the total catecholamine secretion expressed in
pA/s. In the control group (bu¡er-injected), secretion was 868 þ 67
pA/s. Results are expressed relative to the response recorded from
control cells and are given as means þ S.E.M. Identical results were
obtained in three di¡erent cell preparations.
Fig. 4. PhLPs inhibits the intrinsic GTPase activity associated with
puri¢ed plasma or secretory granule membranes from chroma⁄n
cells. GTPase activity associated with puri¢ed chroma⁄n granule
membranes (open circles) or plasma membranes (closed circles) was
assayed by measuring the release of free 32P phosphate from [Q-32P]-
GTP in the presence of the indicated concentrations of recombinant
PhLPs. The intrinsic GTPase activity of the secretory granule mem-
brane was 1.2 nmol/mg/min and of the plasma membrane was 2.1
nmol/mg/min. Assays were performed in triplicate and results are
given as the mean þ S.E.M. This experiment was repeated twice.
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3.4. Conclusion
The present results indicate that the short variant of PhLP
could play a role in the secretory process in chroma⁄n cells.
PhLPs translocates from the subplasmalemmal region to the
cytosol following cell stimulation. Although the functional
signi¢cance of this observation remains to be elucidated, it
is tempting to propose that a phosphorylation reaction may
dissociate PhLPs from the plasma membrane-bound GLQ sub-
units since it has been reported that the a⁄nity of phosphor-
ylated phosducin for GLQ is reduced. Increased levels of
PhLPs in chroma⁄n cells inhibited catecholamine secretion,
suggesting that PhLPs acts as a negative clamp on the molec-
ular machinery underlying exocytosis. At this stage, the part-
ners for PhLPs in the exocytotic pathway remain to be iden-
ti¢ed. It appears reasonable to assume that the e¡ects of
PhLPs on secretion are mediated via the GLQ subunits. In-
deed, recent observations in mast cells indicate that GLQ sub-
units are capable of enhancing the extent of secretion [10]. By
inhibiting the regulatory e¡ects of LQ subunits on K, PhLPs
may a¡ect the role of G proteins in the exocytotic pathway.
We have previously reported that the late ATP-independent
fusion step of exocytosis requires the activation of a plasma
membrane-associated GKi3 protein [8]. PhLPs may act in this
late phase of exocytosis, by inhibiting the activity of GKi3.
The high a⁄nity of PhLPs for the LQ subunits of G proteins
may also have e¡ects that go beyond the alterations of G
protein activation. Hence, GLQ are important not only for
the GTPase activity of the K subunit but also for the regula-
tion of e¡ectors. LQ subunits are able to regulate the activity
of phosphatidylinositol 3-kinase [16], and Rac-dependent
pathways [42] possibly by interacting with nucleotide ex-
change factors with PH domains [43]. Since both phosphati-
dylinositol 3-kinase and Rac1 are present in the subplasma-
lemmal region of chroma⁄n cells and are probably involved
in calcium-regulated catecholamine secretion [17,44], they rep-
resent additional putative downstream pathways for PhLPs in
the exocytotic reaction. Further understanding of the mecha-
nisms by which PhLPs acts in the secretory machinery now
awaits the identi¢cation of the plasma membrane partners for
PhLPs and the elucidation of the role of calcium and phos-
phorylation reactions in the cellular localization of PhLPs in
chroma⁄n cells.
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